Distribution Plan - The company announced a distribution plan for the first half of 2025, proposing a cash dividend of 2 yuan per 10 shares (including tax), with a total expected payout of 80.92 million yuan [2] - The payout amount represents 43.15% of the company's net profit, marking the fourth cumulative cash distribution since its listing [2] Historical Distribution Overview - The company has provided a summary of its past distribution plans, including: - June 30, 2025: 10 shares for 2 yuan (total payout: 81 million yuan, dividend yield: 0.60%) - December 31, 2024: 10 shares for 2.3 yuan (total payout: 93 million yuan, dividend yield: 1.19%) - June 30, 2024: 10 shares for 1.8 yuan (total payout: 73 million yuan, dividend yield: 1.05%) - December 31, 2023: 10 shares for 1.7 yuan (total payout: 69 million yuan, dividend yield: 0.92%) [2] Financial Performance - For the latest half-year report, the company achieved operating revenue of 895 million yuan, reflecting a year-on-year growth of 20.31% [2] - The net profit for the period was 188 million yuan, with a year-on-year increase of 4.16% [2] - Basic earnings per share were reported at 0.46 yuan, and the weighted average return on equity was 8.69% [2] Capital Flow - Recent data indicates that the stock experienced a net outflow of 6.15 million yuan in principal funds today, while there was a net inflow of 6.13 million yuan over the past five days [2] - The latest margin financing balance for the stock stands at 359 million yuan, with an increase of 20.69 million yuan over the past five days, representing a growth rate of 6.12% [3]

证券日报网讯 8月18日晚间，润本股份发布公告称，2025年第二季度主要经营数据如下：驱蚊产品系列 产量52，755，453支，销量63，279，043支，营业收入331，812，579.67元；婴童护理产品系列产量 18，150，829支，销量22，140，539支，营业收入225，705，678.74元；精油产品系列产量9，497， 827支，销量11，568，410支，营业收入81，015，564.27元。主要产品价格变动方面，驱蚊产品系列平 均售价同比下降0.76%，婴童护理产品系列平均售价同比上升6.93%，精油产品系列平均售价同比下降 11.39%。 （文章来源：证券日报） ...

证券日报网讯 8月18日晚间，润本股份发布公告称，2025年半年度公司实现营业收入895，107，556.64 元，同比增长20.31%；归属于上市公司股东的净利润187，524，723.49元，同比增长4.16%；基本每股 收益0.46元，同比增长4.55%。公司拟以实施权益分派股权登记日的总股本为基数，向在册全体股东每 10股派发2.00元现金股利（含税）。 （文章来源：证券日报） ...

证券日报网讯 8月18日晚间，润本股份发布公告称，公司将于2025年9月3日召开2025年第二次临时股东 大会。本次股东大会将审议《关于的议案》《关于取消监事会暨修订的议案》等多项议案。 （文章来源：证券日报） ...

（文章来源：证券日报） 证券日报网讯 8月18日晚间，润本股份发布2025年半年度利润分配方案的公告称，公司拟向全体股东每 10股派发现金红利2.00元（含税）。截至2025年6月30日，公司总股本404，593，314股，以此计算合计 拟派发现金红利80，918，662.80元（含税），占公司2025年半年度合并报表归属于上市公司股东净利 润的比例为43.15%。 ...

Core Insights - Runben Co., Ltd. (603193.SH) reported a revenue of 895 million yuan for the first half of 2025, representing a year-on-year growth of 20.31% [1] - The net profit attributable to shareholders was 188 million yuan, an increase of 4.16% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 177 million yuan, showing a year-on-year growth of 0.86% [1] - Basic earnings per share were 0.46 yuan [1] Business Strategy - The company adhered to an integrated strategy of research, production, and sales, consolidating its advantages in online channels while further expanding offline channels [1] - In response to summer skincare needs for infants and teenagers, the company launched more sunscreen products and expanded its target audience for skincare products from infants to teenagers, introducing an oil control and acne treatment series for teenagers [1] - The company's brand value has further increased, contributing to steady growth in operational performance [1] Dividend Announcement - The company plans to distribute a cash dividend of 2.00 yuan per 10 shares (including tax) to all shareholders [1]

本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 润本生物技术股份有限公司（以下简称"公司"）第二届监事会第六次会议 于2025 年 8 月 18 日在公司会议室以现场方式召开。会议通知已于2025 年 8 月 8 日通过书面文件的方式送达各位监事。本次会议应出席监事 3 人，实际出席监 事 3 人。董事会秘书吴伟斌先生列席了本次会议。本次会议的召集、召开和表决 程序符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 经各位监事认真审议，会议形成了如下决议。 二、监事会会议审议情况 （一）审议通过《关于<2025 年半年度报告及摘要>的议案》 证券代码：603193 证券简称：润本股份 公告编号：2025-033 润本生物技术股份有限公司 具体内容详见公司同日披露于上海证券交易所网站 (www.sse.com.cn) 的《2025 年半年度利润分配方案的公告》（公告编号：2024-030）。 表决结果：3票同意，0票反对，0票弃权。 本议案尚需提交2025年第二次临时股东大会审议。 （三 ...

证券代码：603193 证券简称：润本股份 公告编号：2025-036 润本生物技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 股东大会召开日期：2025年9月3日 ? 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一)股东大会类型和届次 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 9 月 3 日 15 点 00 分 召开地点：广东省广州市天河区珠江新城华夏路 28 号富力盈信大厦 40 楼润 本生物技术股份有限公司会议室 网络投票起止时间：自2025 年 9 月 3 日 至2025 年 9 月 3 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会 ...

关于取消监事会、修订《公司章程》及修订、制定相 关制度的公告 证券代码：603193 证券简称：润本股份 公告编号 2025-035 润本生物技术股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 润本生物技术股份有限公司（以下简称"公司"）于 2025 年 8 月 18 日召开第 二届董事会第九次会议，审议通过了《关于取消监事会的议案》《关于修订 <公司> 章程>的议案》《关于修订、制定 <股东大会议事规则> 等内部管理制度的议案》、 《关于制定〈市值管理制度〉的议案》《关于制定 <信息披露暂缓与豁免业务管理> 制度>》等议案。现将具体内容情况公告如下： 一、取消监事会 为进一步提升公司治理水平，促进公司规范运作，根据《中华人民共和国公司 法》、《关于新 <公司法> 配套制度规则实施相关过渡期安排》以及《上市公司章 程指引（2025 年修订）》等法律、法规及规范性文件的规定，公司拟修订《公司 章程》，不再设置监事会，由董事会审计委员会行使《公司法》规定的监事会职权， 公司《监事会议事规则》相应废止。本事项已经公司第 ...

General Provisions - The company establishes a system to manage the resignation of directors and senior management to ensure governance stability and protect shareholder rights, in accordance with relevant laws and regulations [1][2] - This system applies to all directors and senior management, covering various resignation scenarios such as voluntary resignation, term expiration, dismissal, and replacement [1] Resignation Conditions and Effectiveness - Directors can resign before their term ends by submitting a written resignation report, which becomes effective upon receipt by the company, except in specific circumstances that would violate legal requirements [2][3] - Senior management can also resign before their term ends, with the resignation effective upon the board's receipt of the resignation report [2] - The company must complete the election of new directors within sixty days of a resignation to maintain compliance with legal and regulatory requirements [2] Responsibilities and Obligations After Resignation - Resigning directors and senior management must complete all handover procedures within five days of their resignation, including transferring relevant documents and information [3][4] - The company must disclose details regarding the resignation, including the reason, position, and any ongoing commitments, to ensure transparency [4][5] - Resigning individuals remain bound by their fiduciary duties and confidentiality obligations even after leaving the company [5][6] Accountability Mechanism - If a resigning director or senior management fails to fulfill their commitments or causes losses to the company, the board may pursue accountability measures, including compensation for direct losses and expected benefits [6] - Individuals can appeal the board's accountability decisions within fifteen days of notification [6] Implementation - The system will be effective upon approval by the company's board of directors and will be interpreted by the board [6]